The global Liver Transplant Anti-Rejection Drugs market was valued at US$ 1925 million in 2023 and is anticipated to reach US$ 2395.2 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

Liver Transplant Anti-Rejection Drugs Market

The driving forces for the development of anti-rejection drugs for liver transplantation mainly include the following aspects:

Disease treatment needs: Liver transplantation is an effective method to treat end-stage liver disease, but the occurrence of rejection after transplantation will seriously affect the success rate of transplantation and the patient's quality of life. Therefore, anti-rejection therapy is an important part of post-liver transplantation treatment and promotes the development of anti-rejection drugs for liver transplantation.

Technological progress: With the continuous development of biotechnology, genetic engineering and other technologies, scientists have been able to develop more effective anti-rejection drugs, such as cell therapy, biological agents, nitroglycerin and other new anti-rejection drugs. These drugs have better immunity. Regulatory effects and fewer adverse reactions are one of the important factors promoting the development of anti-rejection drugs for liver transplantation.

Clinical needs: Clinicians need safer and more effective anti-rejection drugs to increase the success rate of transplantation and improve the quality of life of patients. This is also the intrinsic driving force for the development of anti-rejection drugs for liver transplantation.

This report aims to provide a comprehensive presentation of the global market for Liver Transplant Anti-Rejection Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Transplant Anti-Rejection Drugs.

Report Scope

The Liver Transplant Anti-Rejection Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liver Transplant Anti-Rejection Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liver Transplant Anti-Rejection Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Liver Transplant Anti-Rejection Drugs Market Report

Report Metric	Details
Report Name	Liver Transplant Anti-Rejection Drugs Market
Accounted market size in 2023	US$ 1925 million
Forecasted market size in 2030	US$ 2395.2 million
CAGR	3.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Glucocorticoids Anti-Proliferative Drugs T Cell Mediated Immunosuppressants
Segment by Application	Hospital Pharmacy Online Sales Medical Institutions
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, Astellas Pharma Inc., Sanofi Genzyme, Novartis, Asahi Kasei Corporation(Veloxis Pharmaceuticals), Wyeth, Bristol-Myers Squibb Company, Nippon Kayaku, Hansa Biopharma, GSK, AbbVie, Huadong Medicine, North China Pharmaceutical Group, Beijing SL Pharmaceutical, Livzon Pharm, Ruibang Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liver Transplant Anti-Rejection Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liver Transplant Anti-Rejection Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Liver Transplant Anti-Rejection Drugs Market growing?

Ans: The Liver Transplant Anti-Rejection Drugs Market witnessing a CAGR of 3.2% during the forecast period 2024-2030.

What is the Liver Transplant Anti-Rejection Drugs Market size in 2030?

Ans: The Liver Transplant Anti-Rejection Drugs Market size in 2030 will be US$ 2395.2 million.

Who are the main players in the Liver Transplant Anti-Rejection Drugs Market report?

Ans: The main players in the Liver Transplant Anti-Rejection Drugs Market are Roche, Astellas Pharma Inc., Sanofi Genzyme, Novartis, Asahi Kasei Corporation(Veloxis Pharmaceuticals), Wyeth, Bristol-Myers Squibb Company, Nippon Kayaku, Hansa Biopharma, GSK, AbbVie, Huadong Medicine, North China Pharmaceutical Group, Beijing SL Pharmaceutical, Livzon Pharm, Ruibang Pharmaceutical

What are the Application segmentation covered in the Liver Transplant Anti-Rejection Drugs Market report?

Ans: The Applications covered in the Liver Transplant Anti-Rejection Drugs Market report are Hospital, Pharmacy, Online Sales, Medical Institutions

What are the Type segmentation covered in the Liver Transplant Anti-Rejection Drugs Market report?

Ans: The Types covered in the Liver Transplant Anti-Rejection Drugs Market report are Glucocorticoids, Anti-Proliferative Drugs, T Cell Mediated Immunosuppressants

1 Liver Transplant Anti-Rejection Drugs Market Overview

1.1 Product Overview and Scope of Liver Transplant Anti-Rejection Drugs

1.2 Liver Transplant Anti-Rejection Drugs Segment by Type

1.2.1 Global Liver Transplant Anti-Rejection Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Glucocorticoids

1.2.3 Anti-Proliferative Drugs

1.2.4 T Cell Mediated Immunosuppressants

1.3 Liver Transplant Anti-Rejection Drugs Segment by Application

1.3.1 Global Liver Transplant Anti-Rejection Drugs Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Pharmacy

1.3.4 Online Sales

1.3.5 Medical Institutions

1.4 Global Liver Transplant Anti-Rejection Drugs Market Size Estimates and Forecasts

1.4.1 Global Liver Transplant Anti-Rejection Drugs Revenue 2019-2030

1.4.2 Global Liver Transplant Anti-Rejection Drugs Sales 2019-2030

1.4.3 Global Liver Transplant Anti-Rejection Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Liver Transplant Anti-Rejection Drugs Market Competition by Manufacturers

2.1 Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Liver Transplant Anti-Rejection Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Liver Transplant Anti-Rejection Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Liver Transplant Anti-Rejection Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Liver Transplant Anti-Rejection Drugs, Product Type & Application

2.7 Liver Transplant Anti-Rejection Drugs Market Competitive Situation and Trends

2.7.1 Liver Transplant Anti-Rejection Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Liver Transplant Anti-Rejection Drugs Players Market Share by Revenue

2.7.3 Global Liver Transplant Anti-Rejection Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Liver Transplant Anti-Rejection Drugs Retrospective Market Scenario by Region

3.1 Global Liver Transplant Anti-Rejection Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Liver Transplant Anti-Rejection Drugs Global Liver Transplant Anti-Rejection Drugs Sales by Region: 2019-2030

3.2.1 Global Liver Transplant Anti-Rejection Drugs Sales by Region: 2019-2024

3.2.2 Global Liver Transplant Anti-Rejection Drugs Sales by Region: 2025-2030

3.3 Global Liver Transplant Anti-Rejection Drugs Global Liver Transplant Anti-Rejection Drugs Revenue by Region: 2019-2030

3.3.1 Global Liver Transplant Anti-Rejection Drugs Revenue by Region: 2019-2024

3.3.2 Global Liver Transplant Anti-Rejection Drugs Revenue by Region: 2025-2030

3.4 North America Liver Transplant Anti-Rejection Drugs Market Facts & Figures by Country

3.4.1 North America Liver Transplant Anti-Rejection Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2030)

3.4.3 North America Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Liver Transplant Anti-Rejection Drugs Market Facts & Figures by Country

3.5.1 Europe Liver Transplant Anti-Rejection Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2030)

3.5.3 Europe Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Liver Transplant Anti-Rejection Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Liver Transplant Anti-Rejection Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Liver Transplant Anti-Rejection Drugs Market Facts & Figures by Country

3.7.1 Latin America Liver Transplant Anti-Rejection Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2030)

3.7.3 Latin America Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Liver Transplant Anti-Rejection Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Liver Transplant Anti-Rejection Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Liver Transplant Anti-Rejection Drugs Sales by Type (2019-2030)

4.1.1 Global Liver Transplant Anti-Rejection Drugs Sales by Type (2019-2024)

4.1.2 Global Liver Transplant Anti-Rejection Drugs Sales by Type (2025-2030)

4.1.3 Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Type (2019-2030)

4.2 Global Liver Transplant Anti-Rejection Drugs Revenue by Type (2019-2030)

4.2.1 Global Liver Transplant Anti-Rejection Drugs Revenue by Type (2019-2024)

4.2.2 Global Liver Transplant Anti-Rejection Drugs Revenue by Type (2025-2030)

4.2.3 Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Liver Transplant Anti-Rejection Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Liver Transplant Anti-Rejection Drugs Sales by Application (2019-2030)

5.1.1 Global Liver Transplant Anti-Rejection Drugs Sales by Application (2019-2024)

5.1.2 Global Liver Transplant Anti-Rejection Drugs Sales by Application (2025-2030)

5.1.3 Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Application (2019-2030)

5.2 Global Liver Transplant Anti-Rejection Drugs Revenue by Application (2019-2030)

5.2.1 Global Liver Transplant Anti-Rejection Drugs Revenue by Application (2019-2024)

5.2.2 Global Liver Transplant Anti-Rejection Drugs Revenue by Application (2025-2030)

5.2.3 Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Liver Transplant Anti-Rejection Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Corporation Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Roche Liver Transplant Anti-Rejection Drugs Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Astellas Pharma Inc.

6.2.1 Astellas Pharma Inc. Corporation Information

6.2.2 Astellas Pharma Inc. Description and Business Overview

6.2.3 Astellas Pharma Inc. Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Astellas Pharma Inc. Liver Transplant Anti-Rejection Drugs Product Portfolio

6.2.5 Astellas Pharma Inc. Recent Developments/Updates

6.3 Sanofi Genzyme

6.3.1 Sanofi Genzyme Corporation Information

6.3.2 Sanofi Genzyme Description and Business Overview

6.3.3 Sanofi Genzyme Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Genzyme Liver Transplant Anti-Rejection Drugs Product Portfolio

6.3.5 Sanofi Genzyme Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Corporation Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novartis Liver Transplant Anti-Rejection Drugs Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 Asahi Kasei Corporation(Veloxis Pharmaceuticals)

6.5.1 Asahi Kasei Corporation(Veloxis Pharmaceuticals) Corporation Information

6.5.2 Asahi Kasei Corporation(Veloxis Pharmaceuticals) Description and Business Overview

6.5.3 Asahi Kasei Corporation(Veloxis Pharmaceuticals) Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Asahi Kasei Corporation(Veloxis Pharmaceuticals) Liver Transplant Anti-Rejection Drugs Product Portfolio

6.5.5 Asahi Kasei Corporation(Veloxis Pharmaceuticals) Recent Developments/Updates

6.6 Wyeth

6.6.1 Wyeth Corporation Information

6.6.2 Wyeth Description and Business Overview

6.6.3 Wyeth Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Wyeth Liver Transplant Anti-Rejection Drugs Product Portfolio

6.6.5 Wyeth Recent Developments/Updates

6.7 Bristol-Myers Squibb Company

6.6.1 Bristol-Myers Squibb Company Corporation Information

6.6.2 Bristol-Myers Squibb Company Description and Business Overview

6.6.3 Bristol-Myers Squibb Company Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bristol-Myers Squibb Company Liver Transplant Anti-Rejection Drugs Product Portfolio

6.7.5 Bristol-Myers Squibb Company Recent Developments/Updates

6.8 Nippon Kayaku

6.8.1 Nippon Kayaku Corporation Information

6.8.2 Nippon Kayaku Description and Business Overview

6.8.3 Nippon Kayaku Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Nippon Kayaku Liver Transplant Anti-Rejection Drugs Product Portfolio

6.8.5 Nippon Kayaku Recent Developments/Updates

6.9 Hansa Biopharma

6.9.1 Hansa Biopharma Corporation Information

6.9.2 Hansa Biopharma Description and Business Overview

6.9.3 Hansa Biopharma Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Hansa Biopharma Liver Transplant Anti-Rejection Drugs Product Portfolio

6.9.5 Hansa Biopharma Recent Developments/Updates

6.10 GSK

6.10.1 GSK Corporation Information

6.10.2 GSK Description and Business Overview

6.10.3 GSK Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.10.4 GSK Liver Transplant Anti-Rejection Drugs Product Portfolio

6.10.5 GSK Recent Developments/Updates

6.11 AbbVie

6.11.1 AbbVie Corporation Information

6.11.2 AbbVie Liver Transplant Anti-Rejection Drugs Description and Business Overview

6.11.3 AbbVie Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.11.4 AbbVie Liver Transplant Anti-Rejection Drugs Product Portfolio

6.11.5 AbbVie Recent Developments/Updates

6.12 Huadong Medicine

6.12.1 Huadong Medicine Corporation Information

6.12.2 Huadong Medicine Liver Transplant Anti-Rejection Drugs Description and Business Overview

6.12.3 Huadong Medicine Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Huadong Medicine Liver Transplant Anti-Rejection Drugs Product Portfolio

6.12.5 Huadong Medicine Recent Developments/Updates

6.13 North China Pharmaceutical Group

6.13.1 North China Pharmaceutical Group Corporation Information

6.13.2 North China Pharmaceutical Group Liver Transplant Anti-Rejection Drugs Description and Business Overview

6.13.3 North China Pharmaceutical Group Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.13.4 North China Pharmaceutical Group Liver Transplant Anti-Rejection Drugs Product Portfolio

6.13.5 North China Pharmaceutical Group Recent Developments/Updates

6.14 Beijing SL Pharmaceutical

6.14.1 Beijing SL Pharmaceutical Corporation Information

6.14.2 Beijing SL Pharmaceutical Liver Transplant Anti-Rejection Drugs Description and Business Overview

6.14.3 Beijing SL Pharmaceutical Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Beijing SL Pharmaceutical Liver Transplant Anti-Rejection Drugs Product Portfolio

6.14.5 Beijing SL Pharmaceutical Recent Developments/Updates

6.15 Livzon Pharm

6.15.1 Livzon Pharm Corporation Information

6.15.2 Livzon Pharm Liver Transplant Anti-Rejection Drugs Description and Business Overview

6.15.3 Livzon Pharm Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Livzon Pharm Liver Transplant Anti-Rejection Drugs Product Portfolio

6.15.5 Livzon Pharm Recent Developments/Updates

6.16 Ruibang Pharmaceutical

6.16.1 Ruibang Pharmaceutical Corporation Information

6.16.2 Ruibang Pharmaceutical Liver Transplant Anti-Rejection Drugs Description and Business Overview

6.16.3 Ruibang Pharmaceutical Liver Transplant Anti-Rejection Drugs Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Ruibang Pharmaceutical Liver Transplant Anti-Rejection Drugs Product Portfolio

6.16.5 Ruibang Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Liver Transplant Anti-Rejection Drugs Industry Chain Analysis

7.2 Liver Transplant Anti-Rejection Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Liver Transplant Anti-Rejection Drugs Production Mode & Process

7.4 Liver Transplant Anti-Rejection Drugs Sales and Marketing

7.4.1 Liver Transplant Anti-Rejection Drugs Sales Channels

7.4.2 Liver Transplant Anti-Rejection Drugs Distributors

7.5 Liver Transplant Anti-Rejection Drugs Customers

8 Liver Transplant Anti-Rejection Drugs Market Dynamics

8.1 Liver Transplant Anti-Rejection Drugs Industry Trends

8.2 Liver Transplant Anti-Rejection Drugs Market Drivers

8.3 Liver Transplant Anti-Rejection Drugs Market Challenges

8.4 Liver Transplant Anti-Rejection Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bristol Myers Squibb Company

North China Pharmaceutical Group

Beijing SL Pharmaceutical

Livzon Pharm

Ruibang Pharmaceutical

Asahi Kasei Corporation(Veloxis Pharmaceuticals)

List of Tables

Table 1. Global Liver Transplant Anti-Rejection Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Liver Transplant Anti-Rejection Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Liver Transplant Anti-Rejection Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Liver Transplant Anti-Rejection Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Liver Transplant Anti-Rejection Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Liver Transplant Anti-Rejection Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Liver Transplant Anti-Rejection Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Liver Transplant Anti-Rejection Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Liver Transplant Anti-Rejection Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Liver Transplant Anti-Rejection Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Transplant Anti-Rejection Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Liver Transplant Anti-Rejection Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Liver Transplant Anti-Rejection Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Liver Transplant Anti-Rejection Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Liver Transplant Anti-Rejection Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Liver Transplant Anti-Rejection Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Liver Transplant Anti-Rejection Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Liver Transplant Anti-Rejection Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Liver Transplant Anti-Rejection Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Liver Transplant Anti-Rejection Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Liver Transplant Anti-Rejection Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Liver Transplant Anti-Rejection Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Liver Transplant Anti-Rejection Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Liver Transplant Anti-Rejection Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Liver Transplant Anti-Rejection Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Liver Transplant Anti-Rejection Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Liver Transplant Anti-Rejection Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Liver Transplant Anti-Rejection Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Liver Transplant Anti-Rejection Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Liver Transplant Anti-Rejection Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Liver Transplant Anti-Rejection Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Liver Transplant Anti-Rejection Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Liver Transplant Anti-Rejection Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Liver Transplant Anti-Rejection Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Liver Transplant Anti-Rejection Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Type (2019-2024)

Table 59. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Type (2025-2030)

Table 60. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Liver Transplant Anti-Rejection Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Liver Transplant Anti-Rejection Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Liver Transplant Anti-Rejection Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Liver Transplant Anti-Rejection Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Application (2019-2024)

Table 69. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Application (2025-2030)

Table 70. Roche Corporation Information

Table 71. Roche Description and Business Overview

Table 72. Roche Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Roche Liver Transplant Anti-Rejection Drugs Product

Table 74. Roche Recent Developments/Updates

Table 75. Astellas Pharma Inc. Corporation Information

Table 76. Astellas Pharma Inc. Description and Business Overview

Table 77. Astellas Pharma Inc. Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Astellas Pharma Inc. Liver Transplant Anti-Rejection Drugs Product

Table 79. Astellas Pharma Inc. Recent Developments/Updates

Table 80. Sanofi Genzyme Corporation Information

Table 81. Sanofi Genzyme Description and Business Overview

Table 82. Sanofi Genzyme Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi Genzyme Liver Transplant Anti-Rejection Drugs Product

Table 84. Sanofi Genzyme Recent Developments/Updates

Table 85. Novartis Corporation Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Novartis Liver Transplant Anti-Rejection Drugs Product

Table 89. Novartis Recent Developments/Updates

Table 90. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Corporation Information

Table 91. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Description and Business Overview

Table 92. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Liver Transplant Anti-Rejection Drugs Product

Table 94. Asahi Kasei Corporation(Veloxis Pharmaceuticals) Recent Developments/Updates

Table 95. Wyeth Corporation Information

Table 96. Wyeth Description and Business Overview

Table 97. Wyeth Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Wyeth Liver Transplant Anti-Rejection Drugs Product

Table 99. Wyeth Recent Developments/Updates

Table 100. Bristol-Myers Squibb Company Corporation Information

Table 101. Bristol-Myers Squibb Company Description and Business Overview

Table 102. Bristol-Myers Squibb Company Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Bristol-Myers Squibb Company Liver Transplant Anti-Rejection Drugs Product

Table 104. Bristol-Myers Squibb Company Recent Developments/Updates

Table 105. Nippon Kayaku Corporation Information

Table 106. Nippon Kayaku Description and Business Overview

Table 107. Nippon Kayaku Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Nippon Kayaku Liver Transplant Anti-Rejection Drugs Product

Table 109. Nippon Kayaku Recent Developments/Updates

Table 110. Hansa Biopharma Corporation Information

Table 111. Hansa Biopharma Description and Business Overview

Table 112. Hansa Biopharma Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Hansa Biopharma Liver Transplant Anti-Rejection Drugs Product

Table 114. Hansa Biopharma Recent Developments/Updates

Table 115. GSK Corporation Information

Table 116. GSK Description and Business Overview

Table 117. GSK Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. GSK Liver Transplant Anti-Rejection Drugs Product

Table 119. GSK Recent Developments/Updates

Table 120. AbbVie Corporation Information

Table 121. AbbVie Description and Business Overview

Table 122. AbbVie Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. AbbVie Liver Transplant Anti-Rejection Drugs Product

Table 124. AbbVie Recent Developments/Updates

Table 125. Huadong Medicine Corporation Information

Table 126. Huadong Medicine Description and Business Overview

Table 127. Huadong Medicine Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Huadong Medicine Liver Transplant Anti-Rejection Drugs Product

Table 129. Huadong Medicine Recent Developments/Updates

Table 130. North China Pharmaceutical Group Corporation Information

Table 131. North China Pharmaceutical Group Description and Business Overview

Table 132. North China Pharmaceutical Group Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. North China Pharmaceutical Group Liver Transplant Anti-Rejection Drugs Product

Table 134. North China Pharmaceutical Group Recent Developments/Updates

Table 135. Beijing SL Pharmaceutical Corporation Information

Table 136. Beijing SL Pharmaceutical Description and Business Overview

Table 137. Beijing SL Pharmaceutical Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Beijing SL Pharmaceutical Liver Transplant Anti-Rejection Drugs Product

Table 139. Beijing SL Pharmaceutical Recent Developments/Updates

Table 140. Livzon Pharm Corporation Information

Table 141. Livzon Pharm Description and Business Overview

Table 142. Livzon Pharm Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Livzon Pharm Liver Transplant Anti-Rejection Drugs Product

Table 144. Livzon Pharm Recent Developments/Updates

Table 145. Ruibang Pharmaceutical Corporation Information

Table 146. Ruibang Pharmaceutical Description and Business Overview

Table 147. Ruibang Pharmaceutical Liver Transplant Anti-Rejection Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 148. Ruibang Pharmaceutical Liver Transplant Anti-Rejection Drugs Product

Table 149. Ruibang Pharmaceutical Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Liver Transplant Anti-Rejection Drugs Distributors List

Table 153. Liver Transplant Anti-Rejection Drugs Customers List

Table 154. Liver Transplant Anti-Rejection Drugs Market Trends

Table 155. Liver Transplant Anti-Rejection Drugs Market Drivers

Table 156. Liver Transplant Anti-Rejection Drugs Market Challenges

Table 157. Liver Transplant Anti-Rejection Drugs Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Liver Transplant Anti-Rejection Drugs

Figure 2. Global Liver Transplant Anti-Rejection Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Liver Transplant Anti-Rejection Drugs Market Share by Type in 2023 & 2030

Figure 4. Glucocorticoids Product Picture

Figure 5. Anti-Proliferative Drugs Product Picture

Figure 6. T Cell Mediated Immunosuppressants Product Picture

Figure 7. Global Liver Transplant Anti-Rejection Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Liver Transplant Anti-Rejection Drugs Market Share by Application in 2023 & 2030

Figure 9. Hospital

Figure 10. Pharmacy

Figure 11. Online Sales

Figure 12. Medical Institutions

Figure 13. Global Liver Transplant Anti-Rejection Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Liver Transplant Anti-Rejection Drugs Market Size (2019-2030) & (US$ Million)

Figure 15. Global Liver Transplant Anti-Rejection Drugs Sales (2019-2030) & (K Units)

Figure 16. Global Liver Transplant Anti-Rejection Drugs Average Price (US$/Unit) & (2019-2030)

Figure 17. Liver Transplant Anti-Rejection Drugs Report Years Considered

Figure 18. Liver Transplant Anti-Rejection Drugs Sales Share by Manufacturers in 2023

Figure 19. Global Liver Transplant Anti-Rejection Drugs Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Liver Transplant Anti-Rejection Drugs Players: Market Share by Revenue in 2023

Figure 21. Liver Transplant Anti-Rejection Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Liver Transplant Anti-Rejection Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Liver Transplant Anti-Rejection Drugs Sales Market Share by Country (2019-2030)

Figure 24. North America Liver Transplant Anti-Rejection Drugs Revenue Market Share by Country (2019-2030)

Figure 25. United States Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Liver Transplant Anti-Rejection Drugs Sales Market Share by Country (2019-2030)

Figure 28. Europe Liver Transplant Anti-Rejection Drugs Revenue Market Share by Country (2019-2030)

Figure 29. Germany Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Liver Transplant Anti-Rejection Drugs Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Liver Transplant Anti-Rejection Drugs Revenue Market Share by Region (2019-2030)

Figure 36. China Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Southeast Asia Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Liver Transplant Anti-Rejection Drugs Sales Market Share by Country (2019-2030)

Figure 44. Latin America Liver Transplant Anti-Rejection Drugs Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Liver Transplant Anti-Rejection Drugs Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Liver Transplant Anti-Rejection Drugs Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Liver Transplant Anti-Rejection Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Liver Transplant Anti-Rejection Drugs by Type (2019-2030)

Figure 54. Global Revenue Market Share of Liver Transplant Anti-Rejection Drugs by Type (2019-2030)

Figure 55. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Liver Transplant Anti-Rejection Drugs by Application (2019-2030)

Figure 57. Global Revenue Market Share of Liver Transplant Anti-Rejection Drugs by Application (2019-2030)

Figure 58. Global Liver Transplant Anti-Rejection Drugs Price (US$/Unit) by Application (2019-2030)

Figure 59. Liver Transplant Anti-Rejection Drugs Value Chain

Figure 60. Liver Transplant Anti-Rejection Drugs Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions